Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
11,341 total articles
Energy Transfer (ET) delivered a blowout Q1 and raised full-year EBITDA guidance, but the market still prices the business at ~8.7x EV/EBITDA with a near-7% yield. For income-oriented growth investors, ET represents an asymmetric setup: operational tailwinds and cash generation support the distribution while valuation can re-rate if midstream funda…
Synopsys' deeper integration of Ansys assets and a string of product launches (notably the Electronics Digital Twin) make its growth story more predictable. The stock trades at a premium, but healthy free cash flow ($2.28B), a raised FY2026 outlook and accelerating IP/security demand create an asymmetric setup. Enter $512.17, stop $480.00, target $…
Intel has repositioned itself as a critical supplier to cloud providers and national AI infrastructure. Market cap sits near $650B while valuation metrics imply the market is pricing in both risk and future growth. This trade targets a measured upside as Intel monetizes custom AI accelerators and foundry wins; set an explicit entry, stop, and targe…
NVIDIA's market value today reflects a dominant GPU/data-center compute business. But the company is also building two other high-margin, high-leverage franchises - enterprise AI software/services and autonomous/edge systems - that the market is only beginning to price. This trade targets a short-duration re-rating as investors reprioritize recurri…
Immuneering (IMRX) has a visible binary catalyst at the end of the month tied to updated clinical data for atebimetinib (IMM-1-104). The market already prices a polarized outcome: strong upside if survival holds and the program continues to de-risk toward Phase 3; sharp downside if data disappoints. With a $336.8M market cap, strong recent institut…
NICE plunged after a Q1 earnings miss on 05/06/2026 but still shows durable cloud and AI-driven revenue trends. Market cap sits at $5.47B with a PE of 10.7 and a deep technical oversold setup. This trade targets a recovery to $130 over the next 180 trading days with a tight stop below the new 52-week low to limit downside if enterprise demand softe…
PayPal trades at a low-teens to single-digit earnings multiple with $5.5B in free cash flow and an active buyback program. With margins already targeted by management to improve via cost cuts and share reduction, the stock offers a favorable risk-reward for a mid-term swing trade. Entry, stop and target included.
Qualcomm remains uniquely positioned where mobile connectivity, edge AI, and automotive telematics converge. This trade idea lays out a mid-term long with a clear entry, target and stop, aiming to capture incremental revenue growth from chipset ramps and licensing leverage while respecting execution and policy risks.
Crown Holdings (CCK) trades near $100 after a modest pullback. With nearly $1.0B in free cash flow, a 35% dividend hike, and an EV/EBITDA of ~8x, the risk-reward favours a long. This trade targets a re-rating to $120 over the next 180 trading days, with a protective stop at $92.
IREN is a vertically integrated, renewable-powered data center platform that just closed multi-billion dollar AI contracts and targeted acquisitions. The stock sold off after a $2bn convertible note offering, creating a long entry at $55.63. If execution on capacity build, enterprise deals and software stack integration go to plan, ARR could scale …
Dollar General (DG) pulled back sharply after earnings and guidance, leaving the stock trading at about $105.25 with a P/E ~15x, EV/EBITDA ~8.2 and free cash flow near $2.4B. The mix of defensive demand in a softening macro, a reasonable balance sheet and an oversold technical backdrop make DG a practical mid-term long. This trade lays out a clear …
Noah Holdings (NOAH) trades at a narrow market cap of ~$734m with a trailing P/E of 9.6 and a price-to-book around 0.5. Combine a 5.45% dividend yield, improving technicals and a steady asset-management franchise and you have a deep-value setup with asymmetric upside. This trade idea lays out entry, stop and target with catalysts and risks.
Reports that Nvidia has anchored roughly $2 billion to secure photonics capacity (Lumentum-related) change the narrative from 'supply hope' to 'supply locked.' With AI demand intact, strong free cash flow and low leverage, NVDA is a tactical buy on the conviction that this commitment accelerates data-center deployment and raises customer switching …
U.S. Gold (USAU) is a small-cap, permitted gold developer whose CK Gold Project feasibility study shows after-tax NPV(5) of $632M at base case prices and $1.30B at recent spot. The market currently values the equity at roughly $293M, leaving a meaningful mismatch if management can secure project financing and execute development. This trade idea ou…
Brookfield Corporation shows bullish technical momentum with price above the 10/20/50 EMAs, an RSI under 70, and a positive MACD histogram. Combine that setup with a large-cap platform ($103.7B market cap), growing fee/insurance businesses and repeated positive thematic headlines in April-May 2026, and you have a technically-friendly swing entry. T…
Delta's unique refinery business, strong cash generation and low valuation create a practical trade as jet fuel shortages and Strait of Hormuz disruptions lift fuel costs. Enter at $71.00, stop at $65.00, target $82.00 over a mid-term horizon of 45 trading days.
Viatris looks cheap on cash-flow and enterprise multiples and is positioned to shift from a cost-story to a pipeline-driven re-rating in 2026. We upgrade to a long trade: entry $16.92, target $22.00, stop $14.50. The setup pairs strong FCF, an ongoing $650M cost program and multiple regulatory catalysts against manageable leverage and an intact div…
MercadoLibre has deliberately sacrificed near-term margins to fund faster delivery, automation and fintech growth. The market punished the stock after Q1 results, but the company is generating strong free cash flow and now trades at attractive multiples. This trade targets a rebound as operating leverage re-emerges and investors re-price MELI close…
Amkor Technology (AMKR) has been re-rated in 2026 as advanced packaging demand accelerates and the company executes on margin expansion. Recent beats, bullish guidance and a strong cash-flow profile support another mid-term push. This trade idea outlines a tactical long entry, risk controls and the catalysts that could send AMKR higher toward our $…
Babcock & Wilcox (BW) just posted an outsized revenue beat and a dramatic jump in backlog that suggests meaningful revenue visibility ahead. The market is pricing a turnaround into the stock; this trade idea lays out a structured long with defined entry, stop and target while flagging significant legal exposure and execution risk.
Ondas is benefiting from a wave of defense and Drone-as-a-Service spending. With fresh contract wins (including a $68M initial order and World Cup counter-drone work), solid liquidity and an EV of roughly $4.08B, the stock is volatile but offers an asymmetric trade if you size it and manage risk. Entry $9.50, target $15.56, stop $7.50, horizon long…
Corebridge trades at subdued multiples and yields ~3.5%, offering what looks like a value entry. The proposed $22B merger with Equitable and an investor probe complicate the setup: upside is real if deal execution and disclosure risks remain contained, but outcomes are binary enough that position sizing and a hard stop are essential.
Brookfield Asset Management is set up for a strong 2026 driven by record fee-bearing capital formation, strategic acquisitions and steady distributable earnings. The balance sheet looks conservative, earnings quality is improving, and technical momentum supports a tactical long. Trade plan below targets a measured upside to $60 with a clear stop at…
AbbVie delivered a convincing Q1 with $15 billion revenue and accelerating Skyrizi and Rinvoq growth. The company generates roughly $17.8 billion in free cash flow and yields 3.3%, yet the stock trades at lofty multiples that still underprice durable growth. We present a long trade to capture a re-rating as clinical catalysts, label expansions, and…
Tennessee Valley Authority 1999 Series A bonds (TVE) trade at $23.70, yield a modest quarterly distribution and sit below recent moving averages. Fundamentals are mixed - government-backed power operations with thin liquidity and negative free cash flow - but the combination of an imminent distribution, a discounted price to recent highs, and an RS…
